Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent-Reference-Cited by-同舟云学术

Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent

Published:2022-08 Issue: Volume:360 Page:13-20
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Otaegui Irurueta Imanol,González Sucarrats Silvia,Barrón Molina Jose Luis,Pérez de Prado Armando,Massotti Monica,Carmona Ramírez Maria Ángeles,Martí Gerard,Bellera Neus,Serra Bernat,Serra Vicenç,Domingo Enric,López-Benito María,Sabaté Manuel,Ferreira González Ignacio,García del Blanco Bruno

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk;Joner;J. Am. Coll. Cardiol.,2006

2. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N. Engl. J. Med.,2014

3. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies;Tearney;J. Am. Coll. Cardiol.,2012

4. Principles of OCT;Fujimoto,2007

5. Randomized comparison of strut coverage between Ticagrelor and Clopidogrel in acute myocardial infarction at 3-month optical coherence tomography;Kim;Yonsei Med. J.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoatherosclerosis: A Distinctive Pathological Mechanism of Stent Failure;Reviews in Cardiovascular Medicine;2024-03-07

2. A more-Comers populAtion trEated with an ultrathin struts polimer-free Sirolimus stent: an Italian post-maRketing study (the CAESAR registry);Frontiers in Cardiovascular Medicine;2024-01-08

3. Withdrawn: Probucol will Become a New Model for Treating Cerebral Infarction with a High Risk of Hemorrhage;Current Medicinal Chemistry;2024-01-04

4. Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents;Medicina;2023-09-12

5. The Role of Oxidants in Percutaneous Coronary Intervention-Induced Endothelial Dysfunction: Can We Harness Redox Signaling to Improve Clinical Outcomes?;Antioxidants & Redox Signaling;2023-05-01